ABT logo

Abbott Laboratories (ABT) Operating profit

annual operating profit:

$6.83B+$347.00M(+5.36%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT annual operating income is $6.83 billion, with the most recent change of +$347.00 million (+5.36%) on December 31, 2024.
  • During the last 3 years, ABT annual operating profit has fallen by -$1.60 billion (-18.99%).
  • ABT annual operating profit is now -18.99% below its all-time high of $8.43 billion, reached on December 31, 2021.

Performance

ABT Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly operating profit:

$1.91B+$52.00M(+2.80%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT quarterly operating income is $1.91 billion, with the most recent change of +$52.00 million (+2.80%) on December 31, 2024.
  • Over the past year, ABT quarterly operating profit has increased by +$131.00 million (+7.36%).
  • ABT quarterly operating profit is now -34.38% below its all-time high of $2.91 billion, reached on March 31, 2022.

Performance

ABT quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM operating profit:

$6.83B+$131.00M(+1.96%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT TTM operating income is $6.83 billion, with the most recent change of +$131.00 million (+1.96%) on December 31, 2024.
  • Over the past year, ABT TTM operating profit has increased by +$347.00 million (+5.36%).
  • ABT TTM operating profit is now -33.17% below its all-time high of $10.21 billion, reached on June 30, 2022.

Performance

ABT TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ABT Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.4%+7.4%+5.4%
3 y3 years-19.0%+7.4%+5.4%
5 y5 years+50.6%+7.4%+5.4%

ABT Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.0%+5.4%-34.4%+46.5%-33.2%+13.7%
5 y5-year-19.0%+50.6%-34.4%+184.4%-33.2%+69.9%
alltimeall time-19.0%+908.7%-34.4%+170.7%-33.2%+501.5%

Abbott Laboratories Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$6.83B(+5.4%)
$1.91B(+2.8%)
$6.83B(+2.0%)
Sep 2024
-
$1.86B(+11.4%)
$6.69B(+3.3%)
Jun 2024
-
$1.67B(+20.4%)
$6.48B(+2.0%)
Mar 2024
-
$1.39B(-22.1%)
$6.36B(-1.9%)
Dec 2023
$6.48B(-22.5%)
$1.78B(+8.1%)
$6.48B(+7.9%)
Sep 2023
-
$1.65B(+6.8%)
$6.00B(-2.0%)
Jun 2023
-
$1.54B(+2.2%)
$6.13B(-12.0%)
Mar 2023
-
$1.51B(+15.7%)
$6.96B(-16.8%)
Dec 2022
$8.36B(-0.7%)
$1.30B(-26.3%)
$8.36B(-11.4%)
Sep 2022
-
$1.77B(-25.5%)
$9.44B(-7.6%)
Jun 2022
-
$2.38B(-18.4%)
$10.21B(+10.7%)
Mar 2022
-
$2.91B(+22.5%)
$9.23B(+9.5%)
Dec 2021
$8.43B(+57.3%)
$2.38B(-6.6%)
$8.43B(-0.6%)
Sep 2021
-
$2.55B(+82.9%)
$8.48B(+14.1%)
Jun 2021
-
$1.39B(-34.0%)
$7.43B(+10.7%)
Mar 2021
-
$2.11B(-13.3%)
$6.71B(+25.2%)
Dec 2020
$5.36B(+18.2%)
$2.43B(+62.7%)
$5.36B(+24.2%)
Sep 2020
-
$1.50B(+122.5%)
$4.31B(+7.4%)
Jun 2020
-
$672.00M(-11.3%)
$4.02B(-11.7%)
Mar 2020
-
$758.00M(-45.4%)
$4.55B(+0.4%)
Dec 2019
$4.53B(+24.2%)
$1.39B(+15.9%)
$4.53B(+5.2%)
Sep 2019
-
$1.20B(-0.7%)
$4.31B(+4.9%)
Jun 2019
-
$1.21B(+63.2%)
$4.11B(+8.6%)
Mar 2019
-
$739.00M(-36.6%)
$3.78B(+3.6%)
Dec 2018
$3.65B(+133.4%)
$1.17B(+17.1%)
$3.65B(+16.4%)
Sep 2018
-
$995.00M(+12.8%)
$3.14B(+7.8%)
Jun 2018
-
$882.00M(+45.1%)
$2.91B(+20.5%)
Mar 2018
-
$608.00M(-6.6%)
$2.41B(+54.3%)
Dec 2017
$1.56B(-48.3%)
$651.00M(-15.3%)
$1.56B(-8.1%)
Sep 2017
-
$769.00M(+99.2%)
$1.70B(-7.0%)
Jun 2017
-
$386.00M(-259.5%)
$1.83B(-19.0%)
Mar 2017
-
-$242.00M(-130.7%)
$2.26B(-25.3%)
Dec 2016
$3.03B(+5.5%)
$789.00M(-12.0%)
$3.03B(-0.9%)
Sep 2016
-
$897.00M(+9.9%)
$3.05B(+6.4%)
Jun 2016
-
$816.00M(+55.7%)
$2.87B(+3.1%)
Mar 2016
-
$524.00M(-35.7%)
$2.78B(-3.0%)
Dec 2015
$2.87B(+10.3%)
$815.00M(+14.3%)
$2.87B(-0.5%)
Sep 2015
-
$713.00M(-2.2%)
$2.88B(-0.5%)
Jun 2015
-
$729.00M(+19.5%)
$2.90B(+1.8%)
Mar 2015
-
$610.00M(-26.4%)
$2.84B(+9.4%)
Dec 2014
$2.60B(+21.8%)
$829.00M(+13.9%)
$2.60B(+8.4%)
Sep 2014
-
$728.00M(+7.5%)
$2.40B(+11.9%)
Jun 2014
-
$677.00M(+85.5%)
$2.14B(+2.4%)
Mar 2014
-
$365.00M(-41.9%)
$2.09B(-10.7%)
Dec 2013
$2.13B(+56.8%)
$628.00M(+32.8%)
$2.34B(+38.5%)
Sep 2013
-
$473.00M(-24.6%)
$1.69B(+10.7%)
Jun 2013
-
$627.00M(+2.0%)
$1.53B(+4.3%)
Mar 2013
-
$615.00M(-2729.1%)
$1.47B(+7.8%)
Dec 2012
$1.36B(-16.5%)
-$23.39M(-107.5%)
$1.36B(-246.3%)
Sep 2012
-
$310.02M(-45.1%)
-$929.59M(+44.2%)
Jun 2012
-
$564.19M(+10.8%)
-$644.73M(-187.5%)
Mar 2012
-
$509.19M(-122.0%)
$737.04M(-54.8%)
Dec 2011
$1.63B(-74.5%)
-$2.31B(-488.8%)
$1.63B(-72.9%)
Sep 2011
-
$594.88M(-69.4%)
$6.01B(-8.9%)
Jun 2011
-
$1.95B(+38.9%)
$6.60B(+4.2%)
Mar 2011
-
$1.40B(-32.3%)
$6.33B(-1.1%)
Dec 2010
$6.40B(+2.6%)
$2.07B(+75.1%)
$6.40B(+3.3%)
Sep 2010
-
$1.18B(-29.7%)
$6.20B(-6.9%)
Jun 2010
-
$1.68B(+14.3%)
$6.66B(+0.1%)
Mar 2010
-
$1.47B(-21.1%)
$6.65B(+6.6%)
Dec 2009
$6.24B(+7.7%)
$1.86B(+13.7%)
$6.24B(+2.0%)
Sep 2009
-
$1.64B(-1.9%)
$6.11B(+4.1%)
Jun 2009
-
$1.67B(+57.6%)
$5.87B(+3.3%)
Mar 2009
-
$1.06B(-39.1%)
$5.69B(-1.8%)
Dec 2008
$5.79B(+26.5%)
$1.74B(+24.8%)
$5.79B(+4.0%)
Sep 2008
-
$1.40B(-6.0%)
$5.57B(+9.2%)
Jun 2008
-
$1.49B(+27.3%)
$5.10B(+6.2%)
Mar 2008
-
$1.17B(-23.2%)
$4.80B(+4.8%)
Dec 2007
$4.58B(+12.9%)
$1.52B(+63.8%)
$4.58B(+11.3%)
Sep 2007
-
$926.55M(-21.9%)
$4.11B(+0.6%)
Jun 2007
-
$1.19B(+25.2%)
$4.09B(+18.7%)
Mar 2007
-
$947.63M(-10.0%)
$3.45B(-2.7%)
Dec 2006
$4.06B(-7.4%)
$1.05B(+16.6%)
$3.54B(-6.5%)
Sep 2006
-
$903.17M(+66.4%)
$3.79B(+1.5%)
Jun 2006
-
$542.78M(-47.9%)
$3.73B(-12.9%)
Mar 2006
-
$1.04B(-19.8%)
$4.29B(-2.1%)
Dec 2005
$4.38B(+4.8%)
$1.30B(+53.4%)
$4.38B(+2.9%)
Sep 2005
-
$847.81M(-22.6%)
$4.25B(-4.1%)
Jun 2005
-
$1.09B(-3.6%)
$4.44B(+3.1%)
Mar 2005
-
$1.14B(-3.4%)
$4.30B(+3.0%)
Dec 2004
$4.18B
$1.18B(+14.1%)
$4.18B(+3.3%)
Sep 2004
-
$1.03B(+7.3%)
$4.04B(+3.8%)
DateAnnualQuarterlyTTM
Jun 2004
-
$960.46M(-4.9%)
$3.89B(+21.6%)
Mar 2004
-
$1.01B(-3.1%)
$3.20B(+0.9%)
Dec 2003
$3.07B(-5.7%)
$1.04B(+18.1%)
$3.17B(+20.1%)
Sep 2003
-
$882.01M(+229.8%)
$2.64B(-1.2%)
Jun 2003
-
$267.42M(-72.7%)
$2.67B(-16.4%)
Mar 2003
-
$980.49M(+92.0%)
$3.20B(-2.0%)
Dec 2002
$3.26B(+1.1%)
$510.60M(-44.1%)
$3.26B(-9.6%)
Sep 2002
-
$913.40M(+15.5%)
$3.61B(+4.9%)
Jun 2002
-
$790.80M(-24.3%)
$3.44B(+0.6%)
Mar 2002
-
$1.04B(+21.8%)
$3.42B(+6.0%)
Dec 2001
$3.22B(-5.2%)
$858.02M(+15.2%)
$3.22B(-2.0%)
Sep 2001
-
$744.63M(-3.4%)
$3.29B(-1.2%)
Jun 2001
-
$770.51M(-9.5%)
$3.33B(-2.1%)
Mar 2001
-
$851.27M(-7.8%)
$3.40B(-0.0%)
Dec 2000
$3.40B(+8.0%)
$922.92M(+17.6%)
$3.40B(+2.7%)
Sep 2000
-
$784.72M(-6.8%)
$3.31B(+6.6%)
Jun 2000
-
$841.57M(-1.2%)
$3.10B(+0.3%)
Mar 2000
-
$851.36M(+2.2%)
$3.10B(-1.7%)
Dec 1999
$3.15B(+1.0%)
$833.05M(+44.0%)
$3.15B(+0.1%)
Sep 1999
-
$578.47M(-30.5%)
$3.15B(-3.8%)
Jun 1999
-
$832.41M(-8.1%)
$3.27B(+1.6%)
Mar 1999
-
$905.33M(+8.9%)
$3.22B(+3.3%)
Dec 1998
$3.12B(+10.0%)
$831.40M(+18.2%)
$3.12B(+2.2%)
Sep 1998
-
$703.50M(-9.8%)
$3.05B(+2.8%)
Jun 1998
-
$779.69M(-2.9%)
$2.97B(+2.3%)
Mar 1998
-
$802.80M(+5.0%)
$2.90B(+2.4%)
Dec 1997
$2.83B(+8.3%)
$764.30M(+23.0%)
$2.83B(+1.7%)
Sep 1997
-
$621.50M(-12.7%)
$2.79B(+1.7%)
Jun 1997
-
$712.21M(-3.2%)
$2.74B(+2.3%)
Mar 1997
-
$735.81M(+2.8%)
$2.68B(+2.3%)
Dec 1996
$2.62B(+9.8%)
$715.81M(+24.6%)
$2.62B(+2.3%)
Sep 1996
-
$574.71M(-11.8%)
$2.56B(+1.3%)
Jun 1996
-
$651.60M(-3.5%)
$2.53B(+2.3%)
Mar 1996
-
$675.00M(+2.9%)
$2.47B(+3.6%)
Dec 1995
$2.38B(+11.1%)
$655.86M(+20.8%)
$2.38B(+2.9%)
Sep 1995
-
$542.92M(-8.7%)
$2.32B(+2.6%)
Jun 1995
-
$594.65M(+0.9%)
$2.26B(+2.3%)
Mar 1995
-
$589.48M(-0.0%)
$2.21B(+2.9%)
Dec 1994
$2.14B(+11.4%)
$589.70M(+21.8%)
$2.14B(-1.1%)
Sep 1994
-
$484.03M(-10.9%)
$2.17B(+1.8%)
Jun 1994
-
$543.49M(+3.1%)
$2.13B(+6.2%)
Mar 1994
-
$527.00M(-14.2%)
$2.01B(+4.2%)
Dec 1993
$1.92B(+26.1%)
$614.07M(+37.9%)
$1.92B(+8.2%)
Sep 1993
-
$445.20M(+6.2%)
$1.78B(+0.1%)
Jun 1993
-
$419.20M(-5.9%)
$1.78B(+14.0%)
Mar 1993
-
$445.50M(-4.9%)
$1.56B(+2.1%)
Dec 1992
$1.53B(-2.0%)
$468.50M(+5.7%)
$1.53B(+0.5%)
Sep 1992
-
$443.20M(+120.3%)
$1.52B(+6.3%)
Jun 1992
-
$201.20M(-51.3%)
$1.43B(-10.7%)
Mar 1992
-
$413.20M(-10.4%)
$1.60B(+2.7%)
Dec 1991
$1.56B(+10.7%)
$461.40M(+30.9%)
$1.56B(+3.9%)
Sep 1991
-
$352.60M(-5.2%)
$1.50B(+2.0%)
Jun 1991
-
$372.00M(+0.3%)
$1.47B(+1.3%)
Mar 1991
-
$371.00M(-7.9%)
$1.45B(+3.1%)
Dec 1990
$1.41B(+15.1%)
$402.90M(+24.9%)
$1.41B(-182.7%)
Sep 1990
-
$322.60M(-8.5%)
-$1.70B(+138.7%)
Jun 1990
-
$352.70M(+7.6%)
-$712.20M(-380.8%)
Mar 1990
-
$327.90M(-112.1%)
$253.60M(-79.2%)
Dec 1989
$1.22B(+10.8%)
-$2.70B(-306.3%)
$1.22B(-12.5%)
Sep 1989
-
$1.31B(-0.6%)
$1.40B(+7.5%)
Jun 1989
-
$1.32B(+1.8%)
$1.30B(+7.3%)
Mar 1989
-
$1.30B(-151.2%)
$1.21B(+9.7%)
Dec 1988
$1.10B(+9.6%)
-$2.53B(-308.6%)
$1.10B(-25.7%)
Sep 1988
-
$1.21B(-1.4%)
$1.48B(+8.9%)
Jun 1988
-
$1.23B(+3.5%)
$1.36B(+14.3%)
Mar 1988
-
$1.19B(-155.3%)
$1.19B(+18.4%)
Dec 1987
$1.01B(+14.5%)
-$2.15B(-297.0%)
$1.01B(-21.9%)
Sep 1987
-
$1.09B(+2.9%)
$1.29B(+13.2%)
Jun 1987
-
$1.06B(+5.5%)
$1.14B(+11.9%)
Mar 1987
-
$1.00B(-153.8%)
$1.02B(+15.7%)
Dec 1986
$878.60M(+19.2%)
-$1.87B(-298.3%)
$878.60M(-18.3%)
Sep 1986
-
$940.90M(+0.3%)
$1.08B(+12.3%)
Jun 1986
-
$938.00M(+8.4%)
$957.40M(+13.1%)
Mar 1986
-
$865.50M(-151.9%)
$846.40M(+14.8%)
Dec 1985
$737.10M(+8.9%)
-$1.67B(-302.8%)
$737.10M(-11.1%)
Sep 1985
-
$822.70M(-0.5%)
$828.90M(+12.4%)
Jun 1985
-
$827.00M(+9.4%)
$737.40M(+3.6%)
Mar 1985
-
$756.20M(-148.0%)
$711.80M(+5.2%)
Dec 1984
$676.60M
-$1.58B(-315.7%)
$676.70M(-70.0%)
Sep 1984
-
$731.20M(-8.8%)
$2.25B(+48.0%)
Jun 1984
-
$801.40M(+11.1%)
$1.52B(+111.1%)
Mar 1984
-
$721.10M
$721.10M

FAQ

  • What is Abbott Laboratories annual operating income?
  • What is the all time high annual operating profit for Abbott Laboratories?
  • What is Abbott Laboratories annual operating profit year-on-year change?
  • What is Abbott Laboratories quarterly operating income?
  • What is the all time high quarterly operating profit for Abbott Laboratories?
  • What is Abbott Laboratories quarterly operating profit year-on-year change?
  • What is Abbott Laboratories TTM operating income?
  • What is the all time high TTM operating profit for Abbott Laboratories?
  • What is Abbott Laboratories TTM operating profit year-on-year change?

What is Abbott Laboratories annual operating income?

The current annual operating profit of ABT is $6.83B

What is the all time high annual operating profit for Abbott Laboratories?

Abbott Laboratories all-time high annual operating income is $8.43B

What is Abbott Laboratories annual operating profit year-on-year change?

Over the past year, ABT annual operating income has changed by +$347.00M (+5.36%)

What is Abbott Laboratories quarterly operating income?

The current quarterly operating profit of ABT is $1.91B

What is the all time high quarterly operating profit for Abbott Laboratories?

Abbott Laboratories all-time high quarterly operating income is $2.91B

What is Abbott Laboratories quarterly operating profit year-on-year change?

Over the past year, ABT quarterly operating income has changed by +$131.00M (+7.36%)

What is Abbott Laboratories TTM operating income?

The current TTM operating profit of ABT is $6.83B

What is the all time high TTM operating profit for Abbott Laboratories?

Abbott Laboratories all-time high TTM operating income is $10.21B

What is Abbott Laboratories TTM operating profit year-on-year change?

Over the past year, ABT TTM operating income has changed by +$347.00M (+5.36%)
On this page